On April 15, 2026, the FDA announced the removal of BPC-157 from its 503A Category 2 list, effective April 22, 2026, because the original nominations were withdrawn
Strategies to Manage Constipation Managing constipation while on Adderall often involves simple lifestyle changes
Cagrilintide Protocol Mistakes & Troubleshooting Most cagrilintide issues are practical: missed doses, unclear vials, or GI side effects during titration
they also support fat oxidation and may improve insulin sensitivity
PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and compounded tirzepatide injection at $289/mo (or $249/mo on the 6-month plan)making multi-year treatment financially sustainable for far more patients
doi: 10.1111/bjd.12886 42 MoensEVeldhoenM